X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1759) 1759
Book Review (314) 314
Publication (114) 114
Book Chapter (21) 21
Conference Proceeding (20) 20
Dissertation (6) 6
Magazine Article (3) 3
Newspaper Article (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
urothelial cancer (1397) 1397
index medicus (1193) 1193
humans (1082) 1082
oncology (655) 655
male (647) 647
bladder cancer (621) 621
female (586) 586
cancer (584) 584
aged (525) 525
middle aged (505) 505
urology & nephrology (454) 454
chemotherapy (379) 379
urinary bladder neoplasms - pathology (373) 373
adult (280) 280
aged, 80 and over (279) 279
tumors (273) 273
bladder-cancer (245) 245
urinary bladder neoplasms - drug therapy (242) 242
carcinoma (224) 224
prognosis (222) 222
bladder (220) 220
transitional-cell carcinoma (218) 218
cisplatin (205) 205
metastasis (194) 194
treatment outcome (191) 191
urothelial carcinoma (190) 190
risk factors (185) 185
antineoplastic combined chemotherapy protocols - therapeutic use (182) 182
urology (179) 179
carcinoma, transitional cell - pathology (171) 171
transitional-cell-carcinoma (170) 170
urinary bladder neoplasms - genetics (163) 163
care and treatment (162) 162
survival (160) 160
research (158) 158
analysis (148) 148
gemcitabine (148) 148
carcinoma, transitional cell - drug therapy (147) 147
medicine & public health (132) 132
radical cystectomy (132) 132
methotrexate (129) 129
patients (126) 126
retrospective studies (126) 126
vinblastine (126) 126
health aspects (125) 125
advanced urothelial cancer (123) 123
phase-ii trial (123) 123
urothelium - pathology (123) 123
urinary bladder (122) 122
animals (121) 121
doxorubicin (121) 121
expression (120) 120
neoplasm staging (116) 116
cystectomy (115) 115
deoxycytidine - analogs & derivatives (114) 114
urinary bladder neoplasms - mortality (113) 113
cisplatin - administration & dosage (111) 111
urinary bladder neoplasms - surgery (110) 110
diagnosis (107) 107
urologic neoplasms - pathology (107) 107
immunotherapy (106) 106
urinary-bladder (105) 105
neoplasm invasiveness (103) 103
risk (103) 103
gene expression (99) 99
metastases (99) 99
immunohistochemistry (98) 98
urologic neoplasms - drug therapy (95) 95
surgery (93) 93
survival analysis (93) 93
invasiveness (90) 90
urinary bladder neoplasms - metabolism (90) 90
carcinoma, transitional cell - surgery (85) 85
recurrence (85) 85
transitional cell carcinoma (85) 85
medicine (84) 84
carcinoma, transitional cell - mortality (83) 83
genetic aspects (83) 83
development and progression (81) 81
abridged index medicus (80) 80
deoxycytidine - administration & dosage (79) 79
apoptosis (78) 78
cancer therapies (78) 78
pharmacology & pharmacy (78) 78
survival rate (78) 78
urinary bladder neoplasms - epidemiology (78) 78
paclitaxel (77) 77
pathology (77) 77
case-control studies (76) 76
proteins (76) 76
smoking (76) 76
therapy (76) 76
antineoplastic agents - therapeutic use (75) 75
article (75) 75
epidemiology (75) 75
urinary bladder neoplasms - therapy (75) 75
biomarkers (74) 74
disease-free survival (74) 74
follow-up studies (74) 74
medical prognosis (73) 73
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1634) 1634
German (82) 82
Japanese (28) 28
French (15) 15
Spanish (10) 10
Chinese (5) 5
Russian (5) 5
Dutch (2) 2
Croatian (1) 1
Czech (1) 1
Italian (1) 1
Polish (1) 1
Serbian (1) 1
Slovak (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Urology, ISSN 0302-2838, 03/2018, Volume 73, Issue 3, pp. 363 - 371
Multimodal enhanced recovery after surgery (ERAS) regimens have improved outcomes from colorectal surgery. We report the application of ERAS to patients... 
Urothelial cancer | Bladder cancer | Radical cystectomy | ERAS | MORTALITY | BLADDER-CANCER | PROGRAMS | UROLOGY & NEPHROLOGY | STRATEGIES
Journal Article
Annals of oncology : official journal of the European Society for Medical Oncology, ISSN 0923-7534, 05/2019, Volume 30, Issue 6, pp. 970 - 976
Novel second-line treatments are needed for patients with advanced urothelial cancer (UC). Interim analysis of the phase III KEYNOTE-045 study showed a... 
PD-L1 | pembrolizumab | urothelial cancer | Original | PD-1 | Editor's Choice
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 12/2018, Volume 25, Issue S3, pp. 978 - 979
Journal Article
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, ISSN 0360-3016, 05/2018, Volume 101, Issue 1, pp. 236 - 237
Journal Article
Onkourologiya, ISSN 1726-9776, 2018, Volume 14, Issue 3, pp. 85 - 91
Journal Article
Aktuelle Urologie, ISSN 0001-7868, 2018, Volume 49, Issue 5, pp. 412 - 416
Journal Article
Klinichescheskaya Laboratornaya Diagnostika, ISSN 0869-2084, 2018, Volume 63, Issue 3, pp. 169 - 173
Journal Article
World journal of urology, ISSN 0724-4983, 02/2019, pp. 1 - 5
To evaluate the underexplored context of cystoscopy adherent versus non-adherent patients in the follow-up of urothelial high-risk non-muscle-invasive bladder... 
Urothelial cancer | Risk groups | Invasiveness | Mortality | Cytology | Bladder cancer | Cancer
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2017, Volume 376, Issue 11, pp. 1015 - 1026
Journal Article
European Urology, ISSN 0302-2838, 2019
Despite FGFR3 alterations in urothelial cancers being associated with decreased inferred T-cell infiltration, in two large clinical trial cohorts, patients... 
PD-1 blockade | Urothelial cancer | Immune checkpoint blockade | PD-L1 blockade | Bladder cancer | FGFR3 | Index Medicus
Journal Article
European urology, ISSN 0302-2838, 06/2019
Several anti-programmed death-1 (anti-PD-1) and anti-programmed death ligand-1 (anti-PD-L1) antibodies have been approved by regulatory authorities for... 
Journal Article
Journal Article
European Urology, ISSN 0302-2838, 07/2019
BACKGROUNDLimited data compare first-line carboplatin-based chemotherapy and immune checkpoint blockade in cisplatin-ineligible metastatic urothelial carcinoma... 
Index Medicus
Journal Article
Nature, ISSN 0028-0836, 02/2018, Volume 554, Issue 7693, pp. 544 - 548
Therapeutic antibodies that block the programmed death-1 (PD-1)-programmed death-ligand 1 (PD-L1) pathway can induce robust and durable responses in patients... 
METASTATIC MELANOMA | CTLA-4 BLOCKADE | BLADDER-CANCER | THERAPY | LANDSCAPE | SUBTYPES | UROTHELIAL CARCINOMA | MULTIDISCIPLINARY SCIENCES | GENES | ADAPTIVE IMMUNE RESISTANCE | MPDL3280A | CD8-Positive T-Lymphocytes - cytology | Humans | Antibodies, Monoclonal - therapeutic use | Urothelium - pathology | Urologic Neoplasms - pathology | Neoplasm Metastasis | Urologic Neoplasms - drug therapy | Urologic Neoplasms - genetics | Immunotherapy | Antibodies - immunology | Antigens, Neoplasm - metabolism | Transforming Growth Factor beta - antagonists & inhibitors | Antigens, Neoplasm - analysis | Disease Models, Animal | Fibroblasts - metabolism | Antibodies - therapeutic use | Antigens, Neoplasm - immunology | Antibodies, Monoclonal - pharmacology | Treatment Outcome | B7-H1 Antigen - immunology | Urologic Neoplasms - immunology | Antibodies - pharmacology | Tumor Microenvironment - immunology | Collagen - metabolism | Phenotype | Animals | B7-H1 Antigen - antagonists & inhibitors | Signal Transduction - drug effects | Cell Cycle Checkpoints - drug effects | CD8-Positive T-Lymphocytes - drug effects | Urothelium - immunology | Mice | Mutation | CD8-Positive T-Lymphocytes - immunology | Urothelium - drug effects | Transforming Growth Factor beta - metabolism | Cohort Studies | Drug Resistance, Neoplasm - drug effects | PD-1 protein | CD8 antigen | Transforming growth factor-a | Antibodies | Parenchyma | Lymphocytes T | Metastasis | Immunity | Metastases | Genotype & phenotype | Signal transduction | Lymphocytes | Cell cycle | Fibroblasts | Growth factors | Urothelial cancer | Phenotypes | Cytokines | Melanoma | Blocking | Gene expression | Patients | Generalized linear models | Signaling | Stromal cells | Medical prognosis | Collagen | PD-L1 protein | Ligands | Determinants | Infiltration | Cancer | Tumors | Apoptosis | Index Medicus | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Expert Opinion on Biological Therapy, ISSN 1471-2598, 07/2019, Volume 19, Issue 7, pp. 685 - 695
Introduction: Successful results of immuno-oncological drugs in metastatic urothelial cancer have triggered the interest of researchers to test them in the... 
neoadjuvant | NMIBC | biomarkers | bladder cancer | immunotherapy | MIBC | radical cystectomy | Adjuvant | urothelial cancer
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.